Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Diphenhydramine/epinephrine/methylprednisolone

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Adebola AS, et al. The Role of Dupilumab in Refractory Anaphylaxis Secondary to Food Allergy. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.C48 [abstract] Adebola AS, et al. The Role of Dupilumab in Refractory Anaphylaxis Secondary to Food Allergy. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.C48 [abstract]
Metadaten
Titel
Diphenhydramine/epinephrine/methylprednisolone
Lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54038-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Entrectinib

Case report

Clozapine

Case report

Pembrolizumab